Glycomics/ Glycobiology Market worth $3.7 billion- increasing demand with Industry Professionals

Glycomics/ Glycobiology Market worth $3.7 billion- increasing demand with Industry Professionals

The glycomics/glycobiology market is projected to reach USD 3.7 billion by 2027 from USD 1.8 billion in 2022, at a CAGR of 15.5% during the forecast period. Growth in the glycomics/glycobiology market can be attributed to factors such as the collaborations and partnerships among market players for the development of glycobiology products, advanced technology for glycobiology, increasing prevalence of cancer and increased use of glycans as biomarkers to identify diseases.

Access a sample of the Glycomics Market Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=132685525

Key Market Players

The global glycomics/glycobiology market is highly competitive. The prominent players operating in this market include Thermo Fisher Scientific (US), New England Biolabs (US), Merck KGaA (Germany), Promega Corporation (US), Waters Corporation (US), Takara Bio Inc, (Japan), Bio-Techne (US), Agilent Technologies (US), Sumitomo Bakelite Co. Ltd. (Japan), Bruker Corporation (US), Shimadzu Corporation (Japan), Danaher Corporation (US), AMS Bio (UK), Ludger Ltd (UK), Z Biotech, LLC (US), Chemily Glycoscience (US), CD BioGlyco (US), GlycoDiag (France), Kode Biotech Limited (New Zealand), Glyxera GmBH (Germany), Lectenz Bio (US), Glycomix Ltd (UK), IEC Group (Italy), Asparia Glycomics (Spain) and Ray Biotech Life Inc. (US)

Merck KGaA (Germany)

Merck KGaA is also one of the leading players in the glycomics/glycobiology market. The company focuses on inorganic growth strategies such as investment to strengthen its market position. The company invested USD 20.52 Million to build new science laboratory in Switzerland for fostering the experiments and research.

Thermo Fisher  Scientific (US)

Thermo Fisher Scientific held the second position in the glycomics/glycobiology market. The company has entered into collaborations and partnerships with a number of life science companies to develop and promote the use of glycobiology products and is recognized for its contribution in the glycobiology space. TransMIT GmBH (Germany) and OwlStone Medical (UK) are some of the major agreement and collaboration partners of the company.

Agilent Technologies (US)

Agilent Technologies provides a comprehensive portfolio of chromatography systems, along with enzymes, kits, and standards in glycomics/glycobiology market. The company has a strong presence in North America and Europe. The company focuses on product launches and partnerships to maintain its position in the market.

To check our Table of Content in detail @ https://www.marketsandmarkets.com/Market-Reports/glycobiology-market-132685525.html

North America is the fastest-growing region of the glycomics/glycobiology market

North America is estimated to be the fastest-growing segment of the market. The growth of the glycomics/glycobiology market in this region is driven by the presence of prominent market players offering glycomics products, increasing focus on glycomics research and its application in drug development and availability of research infrastructure in the US.

Recent Developments

  • Bruker Corporation (US) acquired the IonSense (US) for expansion of the use of DART Mass spectrometers.
  • GlycoNet (Canada) and BridgeBio Pharma Inc, (US) entered into partnership for developing medicines for treating genetic diseases through glycobiology research.

Take advantage of the current business opportunities in the Glycobiology Market by purchasing a license for the comprehensive market report: https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=132685525

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA : 1-888-600-6441

sales@marketsandmarkets.com


healthcare

96 Blog posts

Comments